Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen

doi:10.1084/jem.168.4.1211

This Article

	Full Text (PDF, 931K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Townsend, A.
	Articles by Smith, G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Townsend, A.
	Articles by Smith, G.


Social Bookmarking

	What's this?

ARTICLES

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen

A Townsend, J Bastin, K Gould, G Brownlee, M Andrew, B Coupar, D Boyle, S Chan and G Smith
Institute for Molecular Medicine, John Radcliffe Hospital, Headington, Oxford.

Vaccinia infection interferes with the presentation of influenza Haemagglutinin (HA) and Nucleoprotein (NP) to class I-restricted CTL. The inhibitory effect is selective for certain epitopes, and is more profound during the late phase of infection. For influenza A/NT/60/68 NP, the block is present during both early and late phases of infection, and is selective for the COOH-terminal epitope defined by peptide 366-379, having no detectable effect on the presentation of the NH2-terminal epitope 50-63. The presentation of HA is inhibited only during the late phase of vaccinia infection. For both proteins, presentation is partially (NP) or completely (HA) restored by expression of rapidly degraded protein fragments in the vaccinia infected target cell. For HA, deletion of the NH2-terminal signal sequence completely overcomes the block. For NP, either a large NH2- terminal deletion or the construction of a rapidly degraded ubiquitin- NP fusion protein partially restores presentation. These results illustrate the relationship between degradation of viral proteins in the cytoplasm of an infected cell and recognition of epitopes at the cell surface by class I-restricted T cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Wang, N., Weber, E., Blum, J. S. (2009). Diminished Intracellular Invariant Chain Expression after Vaccinia Virus Infection. J. Immunol. 183: 1542-1550 [Abstract] [Full Text]
Palmowski, M. J., Parker, M., Choudhuri, K., Chiu, C., Callan, M. F. C., van der Merwe, P. A., Cerundolo, V., Gould, K. G. (2009). A Single-Chain H-2Db Molecule Presenting an Influenza Virus Nucleoprotein Epitope Shows Enhanced Ability at Stimulating CD8+ T Cell Responses In Vivo. J. Immunol. 182: 4565-4571 [Abstract] [Full Text]
Richards, H., Longhi, M. P., Wright, K., Gallimore, A., Ager, A. (2008). CD62L (L-Selectin) Down-Regulation Does Not Affect Memory T Cell Distribution but Failure to Shed Compromises Anti-Viral Immunity. J. Immunol. 180: 198-206 [Abstract] [Full Text]
Goldwich, A., Hahn, S. S. C., Schreiber, S., Meier, S., Kampgen, E., Wagner, R., Lutz, M. B., Schubert, U. (2008). Targeting HIV-1 Gag into the Defective Ribosomal Product Pathway Enhances MHC Class I Antigen Presentation and CD8+ T Cell Activation. J. Immunol. 180: 372-382 [Abstract] [Full Text]
Jing, L., Chong, T. M., Byrd, B., McClurkan, C. L., Huang, J., Story, B. T., Dunkley, K. M., Aldaz-Carroll, L., Eisenberg, R. J., Cohen, G. H., Kwok, W. W., Sette, A., Koelle, D. M. (2007). Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus. J. Immunol. 178: 6374-6386 [Abstract] [Full Text]
Li, P., Wang, N., Zhou, D., Yee, C. S. K., Chang, C.-H., Brutkiewicz, R. R., Blum, J. S. (2005). Disruption of MHC Class II-Restricted Antigen Presentation by Vaccinia Virus. J. Immunol. 175: 6481-6488 [Abstract] [Full Text]
Huang, Y., Fayad, R., Smock, A., Ullrich, A. M., Qiao, L. (2005). Induction of Mucosal and Systemic Immune Responses against Human Carcinoembryonic Antigen by an Oral Vaccine. Cancer Res. 65: 6990-6999 [Abstract] [Full Text]
Ostankovitch, M., Robila, V., Engelhard, V. H. (2005). Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation. J. Immunol. 174: 2544-2551 [Abstract] [Full Text]
Golovina, T. N., Morrison, S. E., Eisenlohr, L. C. (2005). The Impact of Misfolding versus Targeted Degradation on the Efficiency of the MHC Class I-Restricted Antigen Processing. J. Immunol. 174: 2763-2769 [Abstract] [Full Text]
Basler, M., Youhnovski, N., van den Broek, M., Przybylski, M., Groettrup, M. (2004). Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus. J. Immunol. 173: 3925-3934 [Abstract] [Full Text]
Wong, S. B. J., Buck, C. B., Shen, X., Siliciano, R. F. (2004). An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses. J. Immunol. 173: 3073-3083 [Abstract] [Full Text]
Wang, Z., La Rosa, C., Mekhoubad, S., Lacey, S. F., Villacres, M. C., Markel, S., Longmate, J., Ellenhorn, J. D. I., Siliciano, R. F., Buck, C., Britt, W. J., Diamond, D. J. (2004). Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood 104: 847-856 [Abstract] [Full Text]
Bronte, V., Cingarlini, S., Apolloni, E., Serafini, P., Marigo, I., De Santo, C., Macino, B., Marin, O., Zanovello, P. (2003). Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase. J. Immunol. 171: 6396-6405 [Abstract] [Full Text]
Cangemi, G., Morandi, B., D'Agostino, A., Peri, C., Conte, R., Damonte, G., Ferlazzo, G., Biassoni, R., Melioli, G. (2003). IFN-{alpha} mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome. Int Immunol 15: 1415-1421 [Abstract] [Full Text]
Probst, H. C., Tschannen, K., Gallimore, A., Martinic, M., Basler, M., Dumrese, T., Jones, E., van den Broek, M. F. (2003). Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression. J. Immunol. 171: 5415-5422 [Abstract] [Full Text]
Qian, S.-B., Ott, D. E., Schubert, U., Bennink, J. R., Yewdell, J. W. (2002). Fusion Proteins with COOH-terminal Ubiquitin Are Stable and Maintain Dual Functionality in Vivo. J. Biol. Chem. 277: 38818-38826 [Abstract] [Full Text]
Golovina, T. N., Wherry, E. J., Bullock, T. N. J., Eisenlohr, L. C. (2002). Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum. J. Immunol. 168: 2667-2675 [Abstract] [Full Text]
Rimoldi, D., Muehlethaler, K., Salvi, S., Valmori, D., Romero, P., Cerottini, J.-C., Levy, F. (2001). Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope. J. Biol. Chem. 276: 43189-43196 [Abstract] [Full Text]
Potter, P., Tourdot, S., Blanchard, T., Smith, G. L., Gould, K. G. (2001). Differential processing and presentation of the H-2Db-restricted epitope from two different strains of influenza virus nucleoprotein. J. Gen. Virol. 82: 1069-1074 [Abstract] [Full Text]
Yewdell, J., Schubert, U, Bennink, J. (2001). At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci. 114: 845-851 [Abstract]
Shedlock, D. J., Weiner, D. B. (2000). DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 68: 793-806 [Abstract] [Full Text]
Schwarz, K., de Giuli, R., Schmidtke, G., Kostka, S., van den Broek, M., Kim, K. B., Crews, C. M., Kraft, R., Groettrup, M. (2000). The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses. J. Immunol. 164: 6147-6157 [Abstract] [Full Text]
Brander, C., Yang, O. O., Jones, N. G., Lee, Y., Goulder, P., Johnson, R. P., Trocha, A., Colbert, D., Hay, C., Buchbinder, S., Bergmann, C. C., Zweerink, H. J., Wolinsky, S., Blattner, W. A., Kalams, S. A., Walker, B. D. (1999). Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences. J. Virol. 73: 10191-10198 [Abstract] [Full Text]
Gileadi, U., Moins-Teisserenc, H. T., Correa, I., Booth, B. L. Jr., Dunbar, P. R., Sewell, A. K., Trowsdale, J., Phillips, R. E., Cerundolo, V. (1999). Generation of an Immunodominant CTL Epitope Is Affected by Proteasome Subunit Composition and Stability of the Antigenic Protein. J. Immunol. 163: 6045-6052 [Abstract] [Full Text]
Qiu, J.-T., Song, R., Dettenhofer, M., Tian, C., August, T., Felber, B. K., Pavlakis, G. N., Yu, X.-F. (1999). Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses. J. Virol. 73: 9145-9152 [Abstract] [Full Text]
Wherry, E. J., Puorro, K. A., Porgador, A., Eisenlohr, L. C. (1999). The Induction of Virus-Specific CTL as a Function of Increasing Epitope Expression: Responses Rise Steadily Until Excessively High Levels of Epitope Are Attained. J. Immunol. 163: 3735-3745 [Abstract] [Full Text]
Shi, W., Bu, P., Liu, J., Polack, A., Fisher, S., Qiao, L. (1999). Human Papillomavirus Type 16 E7 DNA Vaccine: Mutation in the Open Reading Frame of E7 Enhances Specific Cytotoxic T-Lymphocyte Induction and Antitumor Activity. J. Virol. 73: 7877-7881 [Abstract] [Full Text]
Montoya, M., Del Val, M. (1999). Intracellular Rate-Limiting Steps in MHC Class I Antigen Processing. J. Immunol. 163: 1914-1922 [Abstract] [Full Text]
Ben-Shahar, S., Komlosh, A., Nadav, E., Shaked, I., Ziv, T., Admon, A., DeMartino, G. N., Reiss, Y. (1999). 26 S Proteasome-mediated Production of an Authentic Major Histocompatibility Class I-restricted Epitope from an Intact Protein Substrate. J. Biol. Chem. 274: 21963-21972 [Abstract] [Full Text]
Anton, L. C., Schubert, U., Bacik, I., Princiotta, M. F., Wearsch, P. A., Gibbs, J., Day, P. M., Realini, C., Rechsteiner, M. C., Bennink, J. R., Yewdell, J. W. (1999). Intracellular Localization of Proteasomal Degradation of a Viral Antigen. JCB 146: 113-124 [Abstract] [Full Text]
Ferris, R. L., Hall, C., Sipsas, N. V., Safrit, J. T., Trocha, A., Koup, R. A., Johnson, R. P., Siliciano, R. F. (1999). Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization. J. Immunol. 162: 1324-1332 [Abstract] [Full Text]
Tobery, T., Siliciano, R. F. (1999). Cutting Edge: Induction of Enhanced CTL-Dependent Protective Immunity In Vivo by N-End Rule Targeting of a Model Tumor Antigen. J. Immunol. 162: 639-642 [Abstract] [Full Text]
Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W. (1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol. 72: 8644-8649 [Abstract] [Full Text]
Wood, P., Elliott, T. (1998). Glycan-regulated Antigen Processing of a Protein in the Endoplasmic Reticulum Can Uncover Cryptic Cytotoxic T Cell Epitopes. JEM 188: 773-778 [Abstract] [Full Text]
Benham, A. M., Gromme, M., Neefjes, J. (1998). Allelic Differences in the Relationship Between Proteasome Activity and MHC Class I Peptide Loading. J. Immunol. 161: 83-89 [Abstract] [Full Text]
Anton, L. C., Snyder, H. L., Bennink, J. R., Vinitsky, A., Orlowski, M., Porgador, A., Yewdell, J. W. (1998). Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides. J. Immunol. 160: 4859-4868 [Abstract] [Full Text]
Young, P., Deveraux, Q., Beal, R. E., Pickart, C. M., Rechsteiner, M. (1998). Characterization of Two Polyubiquitin Binding Sites in the 26�S Protease Subunit 5a. J. Biol. Chem. 273: 5461-5467 [Abstract] [Full Text]
Mukherjee, S., Trivedi, P., Dorfman, D. M., Klein, G., Townsend, A. (1998). Murine Cytotoxic T Lymphocytes Recognize an Epitope in an EBNA-1 Fragment, but Fail to Lyse EBNA-1-expressing Mouse Cells. JEM 187: 445-450 [Abstract] [Full Text]
Fu, T.-M., Mylin, L. M., Schell, T. D., Bacik, I., Russ, G., Yewdell, J. W., Bennink, J. R., Tevethia, S. S. (1998). An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40�Large T Antigen Cytotoxic T-Lymphocyte Epitope. J. Virol. 72: 1469-1481 [Abstract] [Full Text]
Hanke, T, Blanchard, T., Schneider, J, Ogg, G., Tan, R, Becker, M, Gilbert, S., Hill, A., Smith, G., McMichael, A (1998). Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J. Gen. Virol. 79: 83-90 [Abstract]
Papadopoulos, K. P., Suciu-Foca, N., Hesdorffer, C. S., Tugulea, S., Maffei, A., Harris, P. E. (1997). Naturally Processed Tissue- and Differentiation Stage-Specific Autologous Peptides Bound by HLA Class I and II Molecules of Chronic Myeloid Leukemia Blasts. Blood 90: 4938-4946 [Abstract] [Full Text]
Liu, M. A. (1997). The immunologist's grail: Vaccines that generate cellular�immunity. Proc. Natl. Acad. Sci. USA 94: 10496-10498 [Full Text]
Ben-Shahar, S., Cassouto, B., Novak, L., Porgador, A., Reiss, Y. (1997). Production of a Specific Major Histocompatibility Complex Class I-restricted Epitope by Ubiquitin-dependent Degradation of Modified Ovalbumin in Lymphocyte Lysate. J. Biol. Chem. 272: 21060-21066 [Abstract] [Full Text]
Bacik, I., Snyder, H. L., Anton, L. C., Russ, G., Chen, W., Bennink, J. R., Urge, L., Otvos, L., Dudkowska, B., Eisenlohr, L., Yewdell, J. W. (1997). Introduction of a Glycosylation Site into a Secreted Protein Provides Evidence for an Alternative Antigen Processing Pathway: Transport of Precursors of Major Histocompatability Complex Class I-Restricted Peptides from the Endoplasmic Reticulum to the Cytosol. JEM 186: 479-487 [Abstract] [Full Text]
Sijts, A. J.�A.�M., Pilip, I., Pamer, E. G. (1997). The Listeria monocytogenes-secreted p60 Protein Is an N-end Rule Substrate in the Cytosol of Infected Cells. IMPLICATIONS FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I ANTIGEN PROCESSING OF BACTERIAL PROTEINS. J. Biol. Chem. 272: 19261-19268 [Abstract] [Full Text]
Steven, N.M., Annels, N.E., Kumar, A., Leese, A.M., Kurilla, M.G., Rickinson, A.B. (1997). Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus-induced Cytotoxic T Cell Response. JEM 185: 1605-1618 [Abstract] [Full Text]
Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A., Moss, B., Restifo, N. P. (1997). Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor�vaccine. Proc. Natl. Acad. Sci. USA 94: 3183-3188 [Abstract] [Full Text]
Tobery, T. W., Siliciano, R. F. (1997). Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization. JEM 185: 909-920 [Abstract] [Full Text]
Gueguen, M., Long, E.�O. (1996). Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the�antigen. Proc. Natl. Acad. Sci. USA 93: 14692-14697 [Abstract] [Full Text]
Shastri, N., Nguyen, V., Gonzalez, F. (1995). Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells. J. Biol. Chem. 270: 1088-1091 [Abstract] [Full Text]
Goldberg, A.L., Gaczynska, M., Grant, E., Michalek, M., Rock, K.L. (1995). Functions of the Proteasome in Antigen Presentation. Cold Spring Harb Symp Quant Biol 60: 479-490 [Abstract]
Tobias, J., Shrader, T., Rocap, G, Varshavsky, A (1991). The N-end rule in bacteria. Science 254: 1374-1377 [Abstract]
Moss, B (1991). Vaccinia virus: a tool for research and vaccine development. Science 252: 1662-1667 [Abstract]
Townsend, A., Ohlen, C., Foster, L., Bastin, J., Ljunggren, H.-G., Karre, K. (1989). A Mutant Cell in Which Association of Class I Heavy and Light Chains Is Induced by Viral Peptides. Cold Spring Harb Symp Quant Biol 54: 299-308 [Abstract]
Emmerich, N. P. N., Nussbaum, A. K., Stevanovic, S., Priemer, M., Toes, R. E. M., Rammensee, H.-G., Schild, H. (2000). The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate. J. Biol. Chem. 275: 21140-21148 [Abstract] [Full Text]
Komlosh, A., Momburg, F., Weinschenk, T., Emmerich, N., Schild, H., Nadav, E., Shaked, I., Reiss, Y. (2001). A Role for a Novel Luminal Endoplasmic Reticulum Aminopeptidase in Final Trimming of 26 S Proteasome-generated Major Histocompatability Complex Class I Antigenic Peptides. J. Biol. Chem. 276: 30050-30056 [Abstract] [Full Text]
Tellam, J., Sherritt, M., Thomson, S., Tellam, R., Moss, D. J., Burrows, S. R., Wiertz, E., Khanna, R. (2001). Targeting of EBNA1 for Rapid Intracellular Degradation Overrides the Inhibitory Effects of the Gly-Ala Repeat Domain and Restores CD8+ T Cell Recognition. J. Biol. Chem. 276: 33353-33360 [Abstract] [Full Text]